These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27562210)

  • 21. Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems.
    Liu F; Shimakami T; Murai K; Shirasaki T; Funaki M; Honda M; Murakami S; Yi M; Tang H; Kaneko S
    Sci Rep; 2016 Aug; 6():30939. PubMed ID: 27484655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission.
    Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramírez R; Muñoz-Fernández MÁ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatitis C virus infection by polyoxometalates.
    Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
    Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.
    Lee M; Yang J; Jo E; Lee JY; Kim HY; Bartenschlager R; Shin EC; Bae YS; Windisch MP
    Sci Rep; 2017 Mar; 7():44676. PubMed ID: 28333153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
    Martin MT; Deming P
    Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
    Bukh J
    J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
    Steinmann E; Whitfield T; Kallis S; Dwek RA; Zitzmann N; Pietschmann T; Bartenschlager R
    Hepatology; 2007 Aug; 46(2):330-8. PubMed ID: 17599777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: Their relevance for developing countries.
    Echeverría N; Betancour G; Gámbaro F; Hernández N; López P; Chiodi D; Sánchez A; Boschi S; Fajardo A; Sóñora M; Moratorio G; Cristina J; Moreno P
    Virus Res; 2016 Sep; 223():140-6. PubMed ID: 27449600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical genetics-based development of small molecules targeting hepatitis C virus.
    Jin G; Lee J; Lee K
    Arch Pharm Res; 2017 Sep; 40(9):1021-1036. PubMed ID: 28856597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.
    Vacas Córdoba E; Arnaiz E; Relloso M; Sánchez-Torres C; García F; Pérez-Álvarez L; Gómez R; de la Mata FJ; Pion M; Muñoz-Fernández MÁ
    AIDS; 2013 May; 27(8):1219-29. PubMed ID: 23925376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system.
    Pomeroy JJ; Drusano GL; Rodriquez JL; Brown AN
    Antiviral Res; 2017 Oct; 146():149-152. PubMed ID: 28882564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
    Relaño-Rodríguez I; Juárez-Sánchez R; Pavicic C; Muñoz E; Muñoz-Fernández MÁ
    J Nanobiotechnology; 2019 May; 17(1):69. PubMed ID: 31113488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C.
    Rivero-Juarez A; Brieva T; Frias M; Rivero A
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):901-910. PubMed ID: 30058394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour.
    Galán M; Sánchez Rodríguez J; Jiménez JL; Relloso M; Maly M; de la Mata FJ; Muñoz-Fernández MA; Gómez R
    Org Biomol Chem; 2014 May; 12(20):3222-37. PubMed ID: 24728319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
    Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
    Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.
    Blanchet M; Sureau C; Guévin C; Seidah NG; Labonté P
    Antiviral Res; 2015 Mar; 115():94-104. PubMed ID: 25573299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C Virus: Viral Quasispecies and Genotypes.
    Tsukiyama-Kohara K; Kohara M
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.